Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study
Titel:
Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study
Auteur:
Xu, Peng-Peng Shi, Zi-Yang Qian, Ying Cheng, Shu Zhu, Yue Jiang, Lu Li, Jian-Feng Fang, Hai Huang, Heng-Ye Yi, Hong-Mei Ouyang, Bin-Sheng Wang, Li Zhao, Wei-Li
Verschenen in:
Lancet. Healthy longevity
Paginering:
Jaargang 3 () nr. 7 pagina's e481-e490
Jaar:
2022
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license